Author

A. P. Lewis

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 2 Organism:human· 2 Assay:protein structure· 2 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Research Focus:database / resource· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

C. Marks· 3 shared J. Shi· 3 shared A. Bujotzek· 2 shared B. Taddese· 2 shared C. Deane· 2 shared M. I. J. Raybould· 2 shared A. Kovaltsuk· 1 shared C. M. Deane· 1 shared

Activity by Year

2018-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 34 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

C. Marks

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Evidence of Antibody Repertoire Functional Convergence through Public Baseline and Shared Response Structures

M. I. J. Raybould, C. Marks, A. Kovaltsuk, A. P. Lewis, J. Shi, C. Deane

The paper investigates functional convergence in human antibody repertoires by analyzing structural commonality in baseline and response antibodies, finding high structural similarity across individuals.

bioRxiv · Mar 17, 2020Immunology

Thera-SAbDab: the Therapeutic Structural Antibody Database

M. I. J. Raybould, C. Marks, A. P. Lewis, J. Shi, A. Bujotzek, B. Taddese, C. Deane

Thera-SAbDab tracks therapeutic antibodies and nanobodies, linking them to structural data and metadata for sequence and target analysis.

bioRxiv · Aug 12, 2019Immunology

The Therapeutic Antibody Profiler (TAP): Five Computational Developability Guidelines

M. Raybould, C. Marks, K. Krawczyk, B. Taddese, J. Nowak, A. P. Lewis, A. Bujotzek, J. Shi, C. M. Deane

The paper introduces TAP, a tool that identifies developability issues in therapeutic antibodies using five computational guidelines based on structural and charge properties.

bioRxiv · Jun 29, 2018Immunology